NEW APPROACHESTO TREATMENT OF FUNGAL INFECTIONS AT WOMEN

Article Sidebar

PDF
Published: 2023-02-05
DOI: https://doi.org/10.66073/researchfocus.v2i1.2881

Main Article Content

F.B. Mirodilova
Tashkent Medical Academy image/svg+xml
F.Kh. Abboskhanova
Tashkent Medical Academy image/svg+xml
Kh.A. Tojimurodov
Tashkent Medical Academy image/svg+xml

Abstract

The article reflects the main problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). Data on the effectiveness of the broad-spectrum antimycotic drug fenticonazole in the treatment of VVC are presented, which makes it possible to increase the effectiveness of treatment and reduce the frequency of relapses of the disease.

Article Details

Issue

Vol. 2 No. 1 (2023): Research Focus International Scientific Journal. Volume 2, Issue 1 (2023)

Section

Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

NEW APPROACHESTO TREATMENT OF FUNGAL INFECTIONS AT WOMEN. (2023). Research Focus International Scientific Journal, 2(1), 369-372. https://doi.org/10.66073/researchfocus.v2i1.2881

References

Mendling W. Vulvovaginalmykosen. Klinikum Frankfurt (Oder), AkademischesLehrkrankenhaus der Humboldt–Universitat (Charite) zu Berlin. Z ArztlFortbildQualitatssich 1998; 92 (3): 175–9.

Rathod S.D., Klausner J.D., Krupp K., Reingold AL, Madhivanan P. Epidemiologic features of vulvovaginal candidiasis among reproductive-age women in India. Infectious Diseases in Obstetrics and Gynecology; 2012. Article ID 859071, 8 p.

Rylander E., Berglund A.-L., Krassny C., Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. SexuallyTransmittedInfections. 2004;80:54–57.

Urogenital candidiasis. Clinical recommendations. RODViK, ROAG, Utl. Ministry of Health of the Russian Federation 2016. М., 2016. 22с. (in Russ).

Glazkova L.K. Etiology, clinic and therapy of vulvovaginal candidiasis // Obstetrics and gynecology. - 2005. - No. 3. – P. 55–58.

Blostein F., Levin-Sparenberg E., Wagner J., Foxman B. Recurrent vulvovaginal candidiasis. Annals of Epidemiology. 2017;27(Suppl. 9):575–582. DOI: 10.1016/j.annepidem.2017.08.010

Kachalina T.S., Grechkanov G.O., Nikishov N.N. and other 125p .

Ozone technologies in obstetrics and gynecology. N. Novgorod. 2007. 292 p.

Kubota T. Chronic and recurrent vulvovaginal candidiasis. Dept of Obstetrics and Gynecology, JuntendoUrayasu Hospital, JuntendoUniv, 2–1–1. Tomioka Urayasu-si, Chiba 279–0021. Nippon Ishinkin Gakkai Zasshi 1998; 39(4):213–8.

Martyshkina E.Yu. Non-contraceptive effects of hormonal contraception. View of Russian and foreign experts. Obstetrics, gynecology and reproduction. 2011; 3:52-54.